Journals / Turkish Journal of Hematology / 2014 / Cilt: 31 - Sayı: 4

The Relationship between P-Selectin Polymorphisms and Thrombosis in Antiphospholipid Syndrome: A Pilot Case-Control Study

Antifosfolipid Sendromunda P-Selectin Polimorfizmi ile Tromboz arasındaki İlişki: Pilot Olgu Kontrol Çalışması

Pages
357–362
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion:Our results suggest that the N562D polymorphism of the DN genotype of P-selectin is associated with an increased risk of thrombosis in patients with APS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The selectins are cell adhesion molecules that mediate the interactions among leukocytes, activated platelets, and endothelial cells.
📊
Key Findings & Data:Genomic DNA was extracted from citrated blood samples of all subjects.
💡
Conclusion & Impact:Conclusion:Our results suggest that the N562D polymorphism of the DN genotype of P-selectin is associated with an increased risk of thrombosis in patients with APS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The selectins are cell adhesion molecules that mediate the interactions among leukocytes, activated platelets, and endothelial cells. We aimed to investigate whether P-selectin polymorphisms are associated with thrombosis in patients with antiphospholipid syndrome (APS). Materials and Methods:The diagnosis and classification of APS were based on the report of an international workshop. Genomic DNA was extracted from citrated blood samples of all subjects. Three single nucleotide polymorphisms associated with the P-selectin coding region (S290N, c.1087G>A; N562D, c.1902G>A; T715P, c.2363A>C) were assessed. Results:There were 26 APS (65%) patients with thrombosis. The number of patients without thrombosis was 14 (35%). The frequency of the N562D-DN genotype was significantly higher in patients with APS than in healthy controls (p=0.003). The frequency of this genotype was significantly higher in patients with APS with thrombosis compared with patients with no thrombosis (p=0.03). The N562D-NN genotype was found at a higher frequency in patients with APS than in healthy controls (p=0.004). Conclusion:Our results suggest that the N562D polymorphism of the DN genotype of P-selectin is associated with an increased risk of thrombosis in patients with APS.

Özet

Amaç: Hücre adezyon molekülü olan selektinler, lökositlerle, aktive plateletler ya da endotel hücreleri arasındaki etkileşime aracılık eder. Bu çalışmada antifosfolipid sendromu (AFS) hastalarında tromboz riski ile P-selektin polimorfizmleri arasındaki ilişkinin araştırılması amaçlanmaktadır Gereç ve Yöntemler: AFS tanısı "International Workshop" tanı ve sınıflandırma kriterleri ile konulmuştur. Hastaların periferik kan örneklerinden DNA elde edilmiştir. P-selektin gen bölgesiyle ilişkili üç tane tek nükleotid polimorfizmi (S290N, c.1087G>A; N562D, c.1902G>A; T715P, c.2363A>C) araştırılarak genotipleri belirlenmiştir. Bulgular: Hasta grubunda 26 trombozlu (%65) AFS olgusu ve 14 (%14) trombozu olmayan AFS olgusu yer almaktadır. Hasta ve kontrol grubu kıyaslandığında incelenen polimorfizmlerden N562D-DN genotipi hasta grubunda anlamlı olarak yüksek bulunmuştur (p=0,003). Yine hasta grubuna bakıldığında trombozlu AFS grubunda trombozu olmayan AFS grubuna kıyasla N562D-DN genotipine anlamlı olarak sık rastlanmıştır (p=0,03). N562D NN genotipi ise kontrol grubunda hasta grubuna oranla daha yüksek sıklıktadır (p=0,004). Sonuç: P-selektin N562D polimorfizmi DN genotipi primer AFS hastalarında tromboz riski ile ilişkili olduğu söylenebilir.

🔖

Cite This Article

KANITEZ, N. A., HANÇER, V. S., ERER, B., İNANÇ, M., DİZ, R. K. (2014). The Relationship between P-Selectin Polymorphisms and Thrombosis in Antiphospholipid Syndrome: A Pilot Case-Control Study. Turkish Journal of Hematology, Cilt: 31 - Sayı: 4, 357–362. https://ajindex.com/articles/412570

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309- 1311
  2. Ishiwata N, Takio K, Katayama M. Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J Biol Chem 1994;269:23708-23715
  3. Albert B, Johnson A, Lewis J, Raf M, Roberts K, Walter P. Molecular Biology of the Cell. 5th ed. New York, Garland Science, 2008
  4. Devreese K, Peerlinck K, Hoylaerts MF. Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants. Blood 2010;28:870-878
  5. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185-1190
  6. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9
  7. Théorêt JF, Yacoub D, Hachem A, Gillis MA, Merhi Y. P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation. Thromb Res 2011;128:243-250
  8. Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 2004;10:171- 178
  9. Ay C, Jungbauer LV, Sailer T, Tengler T, Koder S, Kaider A, Panzer S, Quehenberger P, Pabinger I, Mannhalter C. High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. Clin Chem 2007;53:1235-1243
  10. Ay C, Jungbauer LV, Kaider A, Koder S, Panzer S, Pabinger I, Mannhalter C. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism. Thromb Haemost 2008;99:899-904. 11.Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001;115:451-459. 12.Joseph JE, Donohoe S, Harrison P, Mackie IJ, Machin SJ. Platelet activation and turnover in the primary antiphospholipid syndrome. Lupus 1998;7:333-340. 13.Jacob CO, Reiff A, Armstrong DL, Myones BL, Silverman E, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Nocton JJ, Solomon A, Zidovetzki R. Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using uniquely designed candidate gene p